Topical pluronic F-127 gel application enhances cutaneous wound healing in rats

Acta Histochemica

Volumn 116, Issue 1, 2014, Pages 5-13

  Kant, Vinay ^a   Gopal, Anu ^a   Kumar, Dhirendra ^a   Gopalkrishnan, Anu ^a   Pathak, Nitya N ^a   Kurade, Nitin P ^a   Tandan, Surendra K ^a   Kumar, Dinesh ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Collagen; Microvessel density; Pluronic F 127 gel; Rats; Transforming growth factor beta1; Vascular endothelial growth factor; Wound healing

Indexed keywords

GEL; POLOXAMER;

ANGIOGENESIS; ANIMAL; DRUG EFFECTS; DRUG SCREENING; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GEL; MALE; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION; WISTAR RAT; WOUND HEALING;

ADMINISTRATION, TOPICAL; ANIMALS; DRUG EVALUATION, PRECLINICAL; GELS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; POLOXAMER; RATS, WISTAR; SKIN; SKIN PHYSIOLOGICAL PROCESSES; WOUND HEALING;

EID: 84894906781     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.04.010     Document Type: Article

References (51)

1. Athanasiadis T., Beule A., Robinson B., Robinson S., Shi Z., Wormald P.J. Effects of a novel chitosan gel on mucosal wound healing following endoscopic sinus surgery in a sheep model of chronic rhinosinusitis. Laryngoscope 2008, 118:1088-1094.
2. Attama A.A., Uzor P.F., Nnadi C.O., Okafor C.G. Evaluation of the wound healing activity of gel formulations of leaf extract of Aspila africana Fam. Compositae. J Chem Pharm Res 2011, 3:718-724.
3. Bao P., Kodra A., Tomic-Canic M., Golinko M.S., Ehrlich H.P., Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009, 153:347-358.
4. Brem H., Folkman J. Angiogenesis and basic fibroblast growth factor during wound healing. Bone Formation and Repair. Am Acad Orthop Sur. Rosemont 1994, 213-222. Illinois. C.T. Brighton, G.E. Friedlaender, J.M. Lane (Eds.).
5. Dayan D., Hiss Y., Hirshberg A., Bubis J.J., Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?. Histochemistry 1989, 93:27-29.
6. DiBiase M., Rhodes C. Formulation and evaluation of epidermal growth factor in Pluronic-127 gel. Drug Develop Ind Pharm 1996, 22:823-831.
7. Dong Y.L., Fleming R.Y.D., Yan T.Z., Herndon D.N., Waymack J.P. Effect of ibuprofen on the inflammatory response to surgical wounds. J Trauma 1993, 35:340-343.
8. Dvivedi S., Tiwari S.M., Sharma A. Effect of ibuprofen and diclofenac sodium on experimental wound healing. Ind J Exp Biol 1997, 35:1243-1245.
9. Ehrlich H.P. The role of connective tissue matrix in wound healing. Growth factors and other aspects of wound healing: biological and clinical implications 1988, 243-258. Liss, New York. A. Barbul, E. Pines, M. Caldwell, T.K. Hunt (Eds.).
10. Ehrlick H.P., Grislis G., Hunt T.K. Evidence for the involvement of microtubules in wound contraction. Am J Surg 1977, 133:703-706.
11. Escobar-Chavez J.J., Lopez-Cervantes M.A., Naik Y.N., Kalia D., Quintanar-Guerrero A., Ganem-Quintanar Applications of the thermoreversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharmaceut Sci 2006, 9:339-358.
12. Fowler E.B., Cuenin M.F., Hokett S.D., Peacock M.E., McPherson J.C., Sharawy T.R., Billman M.A. Evaluation of pluronic polyols as carriers for grafting materials: study in rat calvaria defects. J Periodontol 2002, 73:191-197.
13. Goto F., Goto K., Weindel K., Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69:508-517.
14. Greenhalgh D.G. The role of growth factors in wound healing. J Trauma 1996, 41:159-167.
15. Greenhalgh D.G., Sprugel K.H., Murray M.J., Ross R. PDGF and FGF stimulate healing in the genetically diabetic mouse. Am J Pathol 1990, 136:1235-1246.
16. Grillo H.C., Potsaid M.S. Studies in wound healing. IV. Retardation of contraction by local X-irradiation, and observations relating to the origin of fibroblasts in repair. Ann Surg 1961, 154:741-750.
17. Harding K.G., Morris H.L., Patel G.K. Science, medicine and the future: healing chronic wounds. Br Med J 2002, 324:160-163.
18. Inpanya P., Faikrua A., Ounaroon A., Sittichokechaiwut A., Viyoch J. Effects of the blended fibroin/aloe gel film on wound healing in streptozotocin-induced diabetic rats. Biomed Mater 2012, 7:035008.
19. Jain N.K., Shah B.K., Taneja L.N. Nasal absorption of metoprolol tartrate. Ind J Pharm Sci 1991, 53:9-16.
20. Johnson K.E., Wilgus T.A. Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond. J Skin Cancer 2012, (Article ID 483439). 10.1155/2012/483439.
21. Jones M.K., Wang H., Peskar B.M., Levin E., Itani R.M., Sarfeh I.J., Tarnawski A.S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999, 5:1418-1423.
22. Jorgensen E., Hvidt S., Brown W., Schillen K. Effects of salts on the micelllization and gelation of triblock copolymer studied by rheology and light scattering. Macromolecules 1997, 30:2355-2364.
23. Koller C., Buri P. Properties et interet pharmaceutique des gels thermoreversibles a base de poloxamers et poloxamines. S.T.P. Pharma 1987, 3:115-124.
24. Komarcevic A. The modern approach to wound treatment. Med Pregl 2000, 53:363-368.
25. Krischak G.D., Augat P., Claes L., Kinzl L., Beck A. The effects of non-steroidal anti-inflammatory drug application on incisional wound healing in rats. J Wound Care 2007, 16:76-78.
26. Kumar K.P.S., Bhowmik D., Srivastava S., Paswan S., Dutta A.S. Sustained release drug delivery system potential. Pharma Innov 2012, 1:48-60.
27. Lal B.K., Saito S., Pappas P.J., Padberg F.T., Cerveira J.J., Hobson R.W. Altered proliferative responses of dermal fibroblasts to TGF-betal may contribute to chronic venous stasis ulcer. J Vasc Surg 2003, 37:1285-1293.
28. Lenaerts V., Triqueneux C., Quarton M., Rieg-Falson F., Couvreur P. Temperature-dependent rheological behavior of Pluronic F-127. Int J Pharm 1987, 39:121-127.
29. Li H., Sung K.C. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 2000, 69:379-388.
30. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., Roers A., Eming S.A. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010, 184:3964-3977.
31. Malik K., Singh I., Nagpal M., Arora S. Atrigel: a potential parenteral controlled drug delivery system. Der Pharmacia Sinica 2010, 1:74-81.
32. Mathieu D., Linke J.C., Wattel F. Non-healing wounds. Handbook on hyperbaric medicine 2006, 401-427. Springer, Netherlands. D.E. Mathieu (Ed.).
33. Mccartney-Francis N.L., Wahl S.M. TGF-beta and macrophages in the rise and fall of inflammation. TGF-beta and related cytokines in inflammation 2001, 65-90. Birkhauser, Basel. S.N. Breit, S.M. Wahl (Eds.).
34. Medrado A.P., Soares A.P., Santos E.T., Reis S.R., Andrade Z.A. Influence of laser photobiomodulation upon connective tissue remodeling during wound healing. J Photochem Photobiol B 2008, 92:144-152.
35. Nissen N.N., Polverini P.J., Koch A.E., Volin M.V., Gamelli R.L., DiPietro L.A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998, 152:1445-1452.
36. Ono I., Tateshita T., Inoue M. The collagen matrix containing basic fibroblast growth factor on wound contraction. J Biomed Master Res 1999, 48:251-271.
37. Padilla M., Clark G.T., Merrill R.L. Topical medications for oro-facial neuropathic pain: a review. J Am Dent Assoc 2000, 131:2.
38. Peacock EE, Wound repair. In: Wound repair. Saunders: Philadelphia; 1984. p. 38-55.
39. Pereira M.C., Pinho C.B., Medrado A.R.P., Andrade Z.A., Reis S.R.A. Influence of 670nm low-level laser therapy on mast cells and vascular response of cutaneous injuries. J Photochem Photobiol B 2010, 98:188-192.
40. Rizzoni D., Porteri E., Ciuceis C., Sleiman I., Rodella L., Rezzani R., et al. Effect of treatment with Candesartan or Enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension 2005, 45:659-665.
41. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986, 83:4167-4171.
42. Ryu J.M., Chung S.J., Lee M.H., Chang-Kook K., Chang-Koo S. Increased bioavailability of propanolol in rats by retaining thermally gelling liquid suppositories in the rectum. J Control Release 1999, 59:163-172.
43. Stojadinovic O.K.A., Golinko M., Tomic-Canic M., Brem H. A novel, non-angiogenic mechanism of VEGF: stimulation of keratinocyte and fibroblast migration. Wound Repair Regen 2007, A30.
44. Suzuma K., Takagi H., Otani A., Honda Y. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1998, 39:1028-1035.
45. Takzare N., Hosseini M., Hasanzadeh G., Mortazavi H., Takzare A., Habibi P. Influence of Aloe vera gel on dermal wound healing process in rat. Toxicol Mech Meth 2009, 19:73-77.
46. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
47. van Winkle W. Wound contraction. Surg Gyn Obstet 1967, 125:131-142.
48. Vodovotz Y., Bogdan C., Paik J., et al. Mechanism of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993, 178:605-613.
49. Watanabe Y., Lee S.W., Detmar M., Ajioka I., Dvorak H.F. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997, 14:2025-2032.
50. Werner R., Grose S. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
51. Yeon S., Chul J., Moo Y. Poly(ethylene oxide)-poly(ethylene oxide)/ply(∈-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: thermo-responsive drug release behaviors. J Control Rel 2000, 65:345-358.